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The pyridoxal/ZH,O exchange reaction of the a-CH of amino acids is known to be accompanied by racemisation: Thus by using a D-ammo acid 
as the starting material any L-amino acid formed in the reaction will be essentially fully deuterated at its a-position. We have used this method 
to prepare a-deuterated L-valine and inco~rated this biosyn~eti~Ily into L. curei dihydrofoIate reductase. A comparison of the aCH-NH finger- 
print regions of COSY spectra of deuterated and normal DHFR complexes allows one to identify cross-peaks from 15 of the 16 valine residues. 
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1. INTRODUCTION 
Nuclear magnetic resonance studies are being increas- 
ingly used to obtain information about conformations 
and interactions in protein-lig~d complexes. In order 
to undertake such studies it is necessary to obtain 
specific assignments for the ligand and protein 
resonances. For the protein assignments the first stage 
in this procedure is to identify the iH signals of spin 
systems characteristic of particular amino acid types. 
Selective isotopic labelling has proved to be very effec- 
tive in making spin system assignments and numerous 
applications have been reported. For ‘H NMR 
resonances the assignments can be made either by using 
selective deuterium labelling, to remove ‘H signals from 
the spectra [l-S], or by using specific i5N or 13C labell- 
ing to identify the signals from scalar coupled protons 
16-91. Spin system assignments in the NH to CYCH 
‘fingerprint’ region of COSY or HOHAHA spectra are 
essential for subsequent sequential assignment of pro- 
tein spectra. However, the spectra of medium sized pro- 
teins (M, 15-25 kDa) suffer from extensive chemical 
shift degeneracy even in 2D spectra and this complicates 
the analysis of COSY, HOHAHA and NOESY spectra. 
One approach to removing these ambiguities in the 
fingerprint region has been to examine uniformly r3C- 
or “N-1abelled proteins using 3D NOESY-HMQC and 
HOHAHA-HMQC experiments where indirect detec- 
tion of the 13C or i5N nuclei via the coupled ‘H nuclei 
allows the heteronuclear chemical shifts to become 
effective in removing degeneracy in the ‘H chemical 
shifts 16-91. A direct method of removing chemical shift 
degeneracy in this region of the spectrum is to use selec- 
tive cr-deuteration to simplify the ‘H spectrum, and it is 
surprising that there have been relatively few reports of 
such studies [5, lo]. The most extensive work in this area 
has been that of Le Master and Richards [S] who 
demonstrate that selectively cr-deuterated amino acids 
can be incorporated biosynthetically into proteins using 
a transaminase deficient E. coli strain, thereby produc- 
ing selectively deuterated proteins with simplified NMR 
suectra 15, lo]. 
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The conventional method of preparing ar-deuterated 
amino acids is to subject the L-amino acid to a base 
catalysed exchange reaction in the presence of pyridoxal 
in 2H20 [l 1,121 with the final extent of deuteration 
depending upon the reaction conditions, in particular 
on the reaction time. In the presence of Al3 + , pyridoxal 
catalyses exchange at both the cy- and &positions and by 
using this approach Le Master and Richards [l 1] have 
achieved high levels of o- and @-deuteration (>95%) 
for several amino acids. In many instances it is 
necessary to label only the cY-position and this is achiev- 
ed by carrying out the reaction in the absence of the 
polyvalent cations, However, under these conditions, 
some amino acids such as valine and isoleucine are only 
partially a-deuterated even after extended reaction 
times. Since it is desirable to have high deuteration 
Published by Elsevier Science Publ&hers B. V. (Biomedical Division) 
~145793/~/~3.50  1990 Federation of European Biochemical Societies 197 
Volume 272, number 1,2 FEBS LETTERS 
levels we have devised an alternative method for prepar- 
ing deuterated L-amino acids which provides almost 
total a-deuteration. This is based on the fact that in the 
pyridoxaV2H20 exchange reaction the a-deuteration is 
accompanied by racemisation of the amino acids 
[ll, 121. Thus, if a D-amino acid is used as the starting 
material then the L-amino acid found in the racemate 
mixture will be essentially fully deuterated at its CY- 
position. It should be noted that the D/L-mixture can 
be used without resolution in the bacterial growth 
medium since only the L-isomer is incorporated. In this 
present study we demonstrate the method by examining 
the NMR spectrum of a selectively deuterated 
dihydrofolate reductase isolated from Lactobacillus 
casei (MTX/R) grown on a fully defined medium con- 
taining totally a-deuterated L-valine together with the 
other isotopically normal amino acids. The L. casei 
(MTX/R) strain has the advantage of being highly aux- 
atrophic and capable of incorporating any non- 
essential amino acids if these are provided in the 
medium [13], thus, removing the possibility of transfer- 
ring the label into other amino acids. However, there is 
no evidence that it is transaminase deficient and one 
must face the possible complication of losing some of 
the label as a consequence of transaminase activity. 
by selective presaturation during the relaxation delay followed by a 
SCUBA pulse sequence [16]. The DQF-COSY spectrum of the 
isotopically normal DHFR complex was recorded on a Bruker AM500 
spectrometer under similar conditions except that the spectral width 
was 7042 Hz and the water was suppressed by using a simple 
presaturation pulse. 
3. RESULTS AND DISCUSSION 
A comparison of the fingerprint regions of a series of 
DQF-COSY spectra for the deuterated and normal 
DHFR complexes allows one to identify cross-peaks for 
15 of the 16 valine residues: these are all present at nor- 
mal intensity for the isotopically normal sample and at 
a much reduced level for the a-deuterated sample. In 
the spectra shown in Fig. 1, 13 of the 16 valine cross- 
peaks can be immediately detected in this way: two 
2. EXPERIMENTAL 
2.1. Preparation of cy-deuterated valine 
D-valine was subjected to a base catalysed exchange reaction in the 
presence of 99.8% ‘HzO, NaOD and pyridoxal hydrochloride. Initial- 
ly exchangeable protons in the reactants were pre-exchanged with 
deuterium by repeated freeze drying from *HzO. The lyophilised 
material (8.4 g) was then taken up in 72 ml *Hz0 (99.8% *H) in the 
presence of 18 ml of 40% NaOD (99% *H) and 1.46 g of pyridoxal 
hydrochloride (Sigma) and refluxed for 20 h, with two further addi- 
tions of pyridoxal hydrochloride (1.46 g) being made at intervals. 
After this reaction time the extent of deuteration at the o-position was 
determined using ‘H NMR and found to be 85% for the D/L- 
mixture. The final solution was adjusted to pH 6 (with HCI) and then 
lyophilised. 
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2.2. L. casei dihydrofoiate reductase (MTX/R) growth conditions 
The L. casei MTX/R cells were grown at 37°C for 26 h in 40 litres 
of fully defined medium [14] containing the u-deuterated valine mix- 
ture (containing > 99% cr-deuterated L-valine) together with the other 
isotopically normal amino acids. The isolation and purification of L. 
casei dihydrofolate reductase (DHFR) was carried out using methods 
described previously [14]. 
Growth curve experiments using fully defined medium were carried 
out and the results confirm that L. casei MTX/R is fully auxotrophic 
for L-valine and does not grow when L-valine is replaced by D-valine. 
2.3. NMR experiments 
The ‘H NMR spectra were acquired from 0.5 ml, 5 mM samples of 
1: 1 DHFR/methotrexate complexes in an HzO/*HzO (90: 10) solution 
containing 500 mM KC1 and 50 mM potassium phosphate at pH 6.5. 
In the case of the ol-deuterated valine DHFR sample the phase sen- 
sitive DQF COSY spectrum was obtained on a Bruker AM 400 spec- 
trometer at 308K with the carrier frequency placed at the centre of the 
spectrum and a spectral width of 6024 Hz. Quadrature detection in Fi 
was achieved using the TPPI method 1151. Data were recorded in 4 K 
points in t2 for each of 512 tl values. The water signal was suppressed 
6 
Fig. 1. The ‘fingerprint’ region of the 2D DQF COSY ‘H contour plot 
for the dihydrofolate reductase-methotrexate complex recorded at 
308 K. (a) Non-deuterated enzyme. (b) Selectively deuterated enzyme 
incorporating cr-deuterated valine. The positions of the valine cross- 
peaks are circled in the figure. Although the samples were recorded at 
different frequencies (500 and 400 MHz, respectively) the spectra 
presented on the ppm chemical shift scale are directly comparable for 
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cross-peaks are not seen in Fig. la because of the Hz0 
irradiation but these have been observed in other spec- 
tra recorded at different temperatures. One valine 
cross-peak has never been observed, probably because 
of an unusually small JN~ value. The 15 assigned valine 
signals provide ideal starting points for using sequential 
assingment methods to give specific residue 
assignments. In other experiments we have in- 
dependently assigned several of the cross-peaks by iden- 
tifying the unique spin-system patterns for valines in the 
COSY and HOHAHA spectra; however, only 11 of the 
16 valines could be identified unequivocally by this 
method. 
It should be noted that while the presence of weak 
valine cross-peaks in the spectrum of the deuterated 
sample indicates that there has been some loss of the 
deuterium label (probably resulting from transaminase 
action) this is not large enough to prevent clear iden- 
tification of the valine cross-peaks. Careful intensity 
measurements on 9 of the well-resolved cross-peaks in- 
dicates that the level of deuteration retained is 70 + 
10%; clearly at this level there is no problem in identify- 
ing the cross-peaks influenced by the selective deutera- 
tion. Had a D/L-mixture with 85% ar-deuteration been 
prepared from L-valine this would have had a L-valine 
deuteration of only 74% and the final incorporation of 
deuterated valine into DHFR would have been only 
52% making it more difficult to identify the cross-peaks 
affected. This illustrates the advantages of starting with 
- 100% cr-deuterated L-amino acids. 
For much larger proteins (130 kDa) it seems likely 
that extensive selective deuterium labelling in combina- 
tion with ‘5N-labelling and 3D editing techniques will 
provide the spectral simplification necessary for assign- 
ing backbone protons. A particularly useful approach 
would be to incorporate a defined mixture of several 
amino acids with total a-deuteration. Clearly the 
method of ar-deuteration proposed here could be used 
to advantage in such procedures. 
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